{"id":"https://openalex.org/W2265169727","doi":null,"title":"Overcoming the Loss of Mitochondrial Tumor Suppressors by Reactivating HIF Prolyl Hydroxylases","display_name":"Overcoming the Loss of Mitochondrial Tumor Suppressors by Reactivating HIF Prolyl Hydroxylases","publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2265169727","mag":"2265169727"},"language":"en","primary_location":{"id":"mag:2265169727","doi":null,"is_oa":false,"landing_page_url":"https://mct.aacrjournals.org/content/6/11_Supplement/CN08-02","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091741754","display_name":"Eyal Gottlieb","orcid":"https://orcid.org/0000-0002-9770-0956","observed_orcids":["https://orcid.org/0000-0002-9770-0956"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210143228","display_name":"Cancer Research UK Scotland Institute","ror":"https://ror.org/03pv69j64","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I4210143228"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Eyal Gottlieb","raw_affiliation_strings":["Cancer Research UK Beatson Laboratories, Glasgow, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-9770-0956","affiliations":[{"raw_affiliation_string":"Cancer Research UK Beatson Laboratories, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I4210143228"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5091741754"],"corresponding_institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I4210143228"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.21583226,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/succinate-dehydrogenase","display_name":"succinate dehydrogenase","score":0.9419999718666077},{"id":"https://openalex.org/keywords/fumarate-hydratase","display_name":"fumarate hydratase","score":0.9929999709129333},{"id":"https://openalex.org/keywords/prolyl-hydroxylase","display_name":"prolyl hydroxylase","score":0.8889999985694885},{"id":"https://openalex.org/keywords/alpha-ketoglutarate","display_name":"alpha-ketoglutarate","score":0.8289999961853027},{"id":"https://openalex.org/keywords/succinic-acid","display_name":"succinic acid","score":0.8700000047683716},{"id":"https://openalex.org/keywords/fumarate","display_name":"fumarate","score":0.9769999980926514},{"id":"https://openalex.org/keywords/krebs-cycle-metabolites","display_name":"Krebs cycle metabolites","score":0.9549999833106995},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.4860000014305115},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.6700000166893005},{"id":"https://openalex.org/keywords/apoptosis-resistance","display_name":"apoptosis resistance","score":0.6110000014305115},{"id":"https://openalex.org/keywords/tumor-vascularization","display_name":"tumor vascularization","score":0.6949999928474426},{"id":"https://openalex.org/keywords/glycolysis","display_name":"glycolysis","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C2781330172","wikidata":"https://www.wikidata.org/wiki/Q412837","display_name":"Succinate dehydrogenase","level":3,"score":0.7611227035522461},{"id":"https://openalex.org/C165135838","wikidata":"https://www.wikidata.org/wiki/Q133895","display_name":"Citric acid cycle","level":3,"score":0.7202714085578918},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.6766119599342346},{"id":"https://openalex.org/C98539663","wikidata":"https://www.wikidata.org/wiki/Q220599","display_name":"Cytosol","level":3,"score":0.6757464408874512},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.6484683156013489},{"id":"https://openalex.org/C106302636","wikidata":"https://www.wikidata.org/wiki/Q21107515","display_name":"Fumarase","level":3,"score":0.606010377407074},{"id":"https://openalex.org/C28859421","wikidata":"https://www.wikidata.org/wiki/Q39572","display_name":"Mitochondrion","level":2,"score":0.6038795709609985},{"id":"https://openalex.org/C20251656","wikidata":"https://www.wikidata.org/wiki/Q162643","display_name":"Glycolysis","level":3,"score":0.5522598028182983},{"id":"https://openalex.org/C132901563","wikidata":"https://www.wikidata.org/wiki/Q412007","display_name":"Malate dehydrogenase","level":3,"score":0.47933706641197205},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47866830229759216},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.44202956557273865},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1839856207370758},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2265169727","doi":null,"is_oa":false,"landing_page_url":"https://mct.aacrjournals.org/content/6/11_Supplement/CN08-02","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2318659688","https://openalex.org/W2130757625","https://openalex.org/W2005828644","https://openalex.org/W2057199368","https://openalex.org/W2157019496","https://openalex.org/W149387524","https://openalex.org/W2060490290","https://openalex.org/W7067114815","https://openalex.org/W2136749294","https://openalex.org/W2104852749"],"abstract_inverted_index":{"CN08-02":[0],"Succinate":[4,49,166],"dehydrogenase":[5],"(SDH)":[7],"and":[8,25,33,44,115,117,192],"fumarate":[10,43,45],"hydratase":[11],"(FH)":[13],"are":[14,35,221],"tumor":[15,94,113],"suppressors":[16],"which":[17,55],"associated,":[18],"for":[19,139],"the":[20,61,70,85,133,175,179,210,224,248,264,281],"first":[21],"time,":[22],"mitochondrial":[23,126],"enzymes":[24,38,81],"their":[26],"dysfunction":[27],"with":[28,244,285],"cancer":[29,140],"formation.":[30],"Both":[31],"SDH":[32,64,236,289],"FH":[34],"Krebs":[36,52],"cycle":[37,53],"that":[39,92,111,144,154,220,241,271],"convert":[40],"succinate":[41,163,185,214],"to":[42,46,60,69,102,128,184,203,257],"malate,":[47],"respectively.":[48],"or":[50,65,164,290],"fumarate,":[51],"metabolites":[54,127],"accumulate":[56],"in":[57,132,150,172,186,223,235,252,280],"mitochondria":[58],"due":[59],"inactivation":[62,161],"of":[63,77,147,168,182,213,250,262,266,283,288,299],"FH,":[66,291],"leak":[67],"out":[68],"cytosol,":[71],"where":[72,292],"they":[73],"inhibit":[74],"a":[75,108,258],"family":[76],"\u03b1-ketoglutarate-dependent":[78],"prolyl":[79],"hydroxylase":[80],"(PHDs).":[82],"Depending":[83],"on":[84],"PHD":[86,160,169,190,229],"inhibited,":[87],"two":[88],"newly":[89],"recognised":[90],"pathways":[91],"support":[93,228],"maintenance":[95],"may":[96,135,276],"ensue:":[97],"affected":[98],"cells":[99,187,254],"become":[100],"resistant":[101],"certain":[103],"apoptotic":[104],"signals":[105],"and/or":[106],"activate":[107],"pseudo-hypoxic":[109],"response":[110],"enhances":[112],"vascularization":[114],"glycolysis":[116],"is":[118,170],"conveyed":[119],"by":[120,157,162],"hypoxia":[121],"inducible":[122],"factor":[123],"(HIF).\u2028":[124],"Demonstrating":[125],"be":[129],"functional":[130,286],"regulators":[131],"cytosol":[134],"indicate":[136],"novel":[137],"targets":[138],"therapy.":[141],"We":[142],"showed":[143],"an":[145,151],"excess":[146],"\u03b1-ketoglutarate,":[148],"provided":[149],"ester":[152],"form":[153],"allows":[155],"uptake":[156],"cells,":[158,201],"overcomes":[159],"fumarate.":[165],"inhibition":[167],"competitive":[171],"nature,":[173],"therefore":[174],"ratio,":[176],"rather":[177],"than":[178],"absolute":[180],"concentrations,":[181],"\u03b1-ketoglutarate":[183,196,206,218,251,274],"critically":[188],"affect":[189],"activity":[191,230],"HIF1\u03b1":[193,233],"stability.":[194],"Native":[195],"does":[197],"not":[198],"readily":[199,245],"enter":[200],"so":[202],"test":[204],"whether":[205],"can":[207],"indeed":[208],"counter":[209],"PHD-inhibiting":[211],"effect":[212,265],"we":[215],"designed":[216,273],"cell-permeating":[217],"derivatives":[219,227,275],"hydrolyzed":[222],"cytosol.":[225],"These":[226],"thereby":[231],"lowering":[232],"levels":[234,298],"deficient":[237],"cells.":[238],"This":[239],"indicates":[240],"upon":[242],"treatment":[243,282],"permeating":[246],"drugs,":[247],"concentration":[249],"target":[253],"will":[255],"rise":[256],"level":[259],"fully":[260],"capable":[261],"countering":[263],"succinate.":[267],"Our":[268],"study":[269],"suggests":[270],"well":[272],"have":[277],"therapeutic":[278],"potential":[279],"tumors":[284],"down-regulation":[287],"it":[293],"could":[294],"restore":[295],"normal":[296],"low":[297],"HIF1\u03b1.":[300]},"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}